• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人骨肉瘤中 WW0X、RUNX2 和 VEGFA 蛋白表达的相关性。

Correlation of WWOX, RUNX2 and VEGFA protein expression in human osteosarcoma.

机构信息

Department of Bone and Soft Tissue Tumor, Tianjin Medical University Cancer Hospital & Institute, Tianjin 300060, China.

出版信息

BMC Med Genomics. 2013 Dec 15;6:56. doi: 10.1186/1755-8794-6-56.

DOI:10.1186/1755-8794-6-56
PMID:24330824
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3878685/
Abstract

BACKGROUND

To investigate associations between WW domain-containing oxidoreductase (WWOX), runt-related transcription factor 2 (RUNX2) and vascular endothelial growth factor alpha (VEGFA) in human osteosarcoma (OS).

METHODS

Copy number aberrations of WWOX, RUNX2and VEGFA genes were detected by microarray comparative genomic hybridization (aCGH) in 10 fresh OS tissue samples. VEGFA gene alterations were also investigated and validated by fluorescence in situ hybridization (FISH) in 54 formalin-fixed and paraffin-embedded (FFPE) OS samples. Protein expression of WWOX, RUNX2 and VEGFA were examined in 54 FFPE OS samples by immunohistochemistry (IHC).

RESULTS

Analysis of previously published OS aCGH data (GSE9654) and aCGH data from this study (GSE19180) identified significant deletion of WWOX in 30% (6/20) of OS samples, whilst significant increase in both RUNX2 and VEGFA gene copy numbers were detected in 55% (11/20) and 60% (12/20) of OS samples, respectively. FISH demonstrated increased VEGFA gene copy number in 65.9% (31/47) of evaluable samples, in either focal or large fragment forms. Compared with positive expression of WWOX in 38.9% of the OS samples, positive expression of RUNX2 and VEGFA protein was found in 48.1 and 75.9% of samples. Although there was no significant association between gene copy number aberration and protein expression for WWOX and RUNX2, significant positive correlation between increased VEGFA gene copy number and VEGFA protein expression was observed. Although there was no significant reverse association between WWOX and RUNX2 expression, a significantly positive relationship was observed between RUNX2 and VEGFA protein expression.

CONCLUSIONS

Our data show increased RUNX2 and VEGFA gene copy numbers and elevation of their respective proteins in human OS. Positive correlation of RUNX2 and VEGFA suggests that both increased VEGFA gene copy number and RUNX2 overexpression facilitate increased expression of VEGFA.

摘要

背景

研究 WW 结构域包含的氧化还原酶(WWOX)、 runt 相关转录因子 2(RUNX2)和血管内皮生长因子 alpha(VEGFA)在人骨肉瘤(OS)中的关联。

方法

通过微阵列比较基因组杂交(aCGH)在 10 例新鲜 OS 组织样本中检测 WWOX、RUNX2 和 VEGFA 基因的拷贝数异常。在 54 例福尔马林固定和石蜡包埋(FFPE)OS 样本中通过荧光原位杂交(FISH)也研究和验证了 VEGFA 基因的改变。通过免疫组织化学(IHC)检测 54 例 FFPE OS 样本中 WWOX、RUNX2 和 VEGFA 的蛋白表达。

结果

分析先前发表的 OS aCGH 数据(GSE9654)和本研究的 aCGH 数据(GSE19180),发现 30%(6/20)的 OS 样本中存在 WWOX 的显著缺失,而 RUNX2 和 VEGFA 基因拷贝数的显著增加分别在 55%(11/20)和 60%(12/20)的 OS 样本中检测到。FISH 显示在 65.9%(31/47)可评估样本中存在 VEGFA 基因拷贝数增加,表现为局灶性或大片段形式。与 OS 样本中 WWOX 阳性表达的 38.9%相比,RUNX2 和 VEGFA 蛋白的阳性表达分别在 48.1%和 75.9%的样本中发现。尽管 WWOX 和 RUNX2 的基因拷贝数异常与蛋白表达之间没有显著关联,但 VEGFA 基因拷贝数的增加与 VEGFA 蛋白表达之间存在显著的正相关。尽管 WWOX 和 RUNX2 表达之间没有显著的反向关联,但观察到 RUNX2 和 VEGFA 蛋白表达之间存在显著的正相关关系。

结论

我们的数据显示,人骨肉瘤中 RUNX2 和 VEGFA 基因的拷贝数增加,相应蛋白水平升高。RUNX2 和 VEGFA 的正相关表明,VEGFA 基因拷贝数的增加和 RUNX2 的过表达都促进了 VEGFA 的表达。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fff/3878685/3ba4e4855937/1755-8794-6-56-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fff/3878685/22b707e1ecf9/1755-8794-6-56-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fff/3878685/5b4aea561f15/1755-8794-6-56-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fff/3878685/3ba4e4855937/1755-8794-6-56-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fff/3878685/22b707e1ecf9/1755-8794-6-56-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fff/3878685/5b4aea561f15/1755-8794-6-56-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fff/3878685/3ba4e4855937/1755-8794-6-56-3.jpg

相似文献

1
Correlation of WWOX, RUNX2 and VEGFA protein expression in human osteosarcoma.人骨肉瘤中 WW0X、RUNX2 和 VEGFA 蛋白表达的相关性。
BMC Med Genomics. 2013 Dec 15;6:56. doi: 10.1186/1755-8794-6-56.
2
Frequent attenuation of the WWOX tumor suppressor in osteosarcoma is associated with increased tumorigenicity and aberrant RUNX2 expression.骨肉瘤中 WW0X 肿瘤抑制因子的频繁失活与致瘤性增加和 RUNX2 表达异常有关。
Cancer Res. 2010 Jul 1;70(13):5577-86. doi: 10.1158/0008-5472.CAN-09-4602. Epub 2010 Jun 8.
3
Deletion of the WWOX gene and frequent loss of its protein expression in human osteosarcoma.人类骨肉瘤中 WW0X 基因缺失及其蛋白表达频繁丢失。
Cancer Lett. 2010 May 1;291(1):31-8. doi: 10.1016/j.canlet.2009.09.018. Epub 2009 Nov 6.
4
Deregulated WWOX is involved in a negative feedback loop with microRNA-214-3p in osteosarcoma.WWOX失调与骨肉瘤中microRNA-214-3p形成负反馈回路。
Int J Mol Med. 2016 Dec;38(6):1850-1856. doi: 10.3892/ijmm.2016.2800. Epub 2016 Nov 10.
5
Genetic amplification of the vascular endothelial growth factor (VEGF) pathway genes, including VEGFA, in human osteosarcoma.人类骨肉瘤中血管内皮生长因子(VEGF)通路基因(包括 VEGFA)的遗传扩增。
Cancer. 2011 Nov 1;117(21):4925-38. doi: 10.1002/cncr.26116. Epub 2011 Apr 14.
6
MicroRNA-34c inversely couples the biological functions of the runt-related transcription factor RUNX2 and the tumor suppressor p53 in osteosarcoma.微小 RNA-34c 反式调控 runt 相关转录因子 RUNX2 和抑癌基因 p53 在骨肉瘤中的生物学功能。
J Biol Chem. 2013 Jul 19;288(29):21307-21319. doi: 10.1074/jbc.M112.445890. Epub 2013 May 29.
7
Characterization of canine osteosarcoma by array comparative genomic hybridization and RT-qPCR: signatures of genomic imbalance in canine osteosarcoma parallel the human counterpart.应用 array-CGH 和 RT-qPCR 对犬骨肉瘤进行特征分析:犬骨肉瘤的基因组失衡特征与人骨肉瘤相似。
Genes Chromosomes Cancer. 2011 Nov;50(11):859-74. doi: 10.1002/gcc.20908. Epub 2011 Aug 11.
8
RUNX2 (6p21.1) amplification in osteosarcoma.RUNX2(6p21.1)在骨肉瘤中的扩增。
Hum Pathol. 2019 Dec;94:23-28. doi: 10.1016/j.humpath.2019.09.010. Epub 2019 Oct 25.
9
WWOX inhibits the invasion of lung cancer cells by downregulating RUNX2.WWOX通过下调RUNX2抑制肺癌细胞的侵袭。
Cancer Gene Ther. 2016 Dec;23(12):433-438. doi: 10.1038/cgt.2016.59. Epub 2016 Nov 11.
10
MicroRNA-205 acts as a tumor suppressor in osteosarcoma via targeting RUNX2.微小RNA-205通过靶向RUNX2在骨肉瘤中发挥肿瘤抑制作用。
Oncol Rep. 2016 Jun;35(6):3275-84. doi: 10.3892/or.2016.4700. Epub 2016 Mar 23.

引用本文的文献

1
Development of a propionate metabolism-related gene-based molecular subtypes and scoring system for predicting prognosis in bladder cancer.建立基于丙酸代谢相关基因的分子亚型和评分系统,预测膀胱癌的预后。
Eur J Med Res. 2024 Jul 29;29(1):393. doi: 10.1186/s40001-024-01982-6.
2
Age-dependent molecular variations in osteosarcoma: implications for precision oncology across pediatric, adolescent, and adult patients.骨肉瘤中年龄依赖性分子变异:对儿科、青少年和成年患者精准肿瘤学的意义。
Front Oncol. 2024 May 22;14:1382276. doi: 10.3389/fonc.2024.1382276. eCollection 2024.
3
Unveiling the Protective Role of Melatonin in Osteosarcoma: Current Knowledge and Limitations.

本文引用的文献

1
Definition of a fluorescence in-situ hybridization score identifies high- and low-level FGFR1 amplification types in squamous cell lung cancer.定义荧光原位杂交评分可识别鳞状细胞肺癌中的高水平和低水平 FGFR1 扩增类型。
Mod Pathol. 2012 Nov;25(11):1473-80. doi: 10.1038/modpathol.2012.102. Epub 2012 Jun 8.
2
Role of the WWOX tumor suppressor gene in bone homeostasis and the pathogenesis of osteosarcoma.WWOX 肿瘤抑制基因在骨稳态和骨肉瘤发病机制中的作用。
Am J Cancer Res. 2011;1(5):585-94. Epub 2011 Apr 3.
3
Genetic amplification of the vascular endothelial growth factor (VEGF) pathway genes, including VEGFA, in human osteosarcoma.
揭示褪黑素在骨肉瘤中的保护作用:当前的认识和局限性。
Biomolecules. 2024 Jan 24;14(2):145. doi: 10.3390/biom14020145.
4
Identify and validate RUNX2 and LAMA2 as novel prognostic signatures and correlate with immune infiltrates in bladder cancer.鉴定并验证RUNX2和LAMA2作为膀胱癌新的预后标志物,并与免疫浸润相关联。
Front Oncol. 2023 Jul 13;13:1191398. doi: 10.3389/fonc.2023.1191398. eCollection 2023.
5
Endocrine regulation and metabolic mechanisms of osteopontin in the development and progression of osteosarcoma, metastasis and prognosis.骨桥蛋白在骨肉瘤发生发展、转移和预后中的内分泌调节和代谢机制。
Front Endocrinol (Lausanne). 2023 Jan 13;13:1100063. doi: 10.3389/fendo.2022.1100063. eCollection 2022.
6
Introducing Fluorescence-Guided Surgery for Pediatric Ewing, Osteo-, and Rhabdomyosarcomas: A Literature Review.小儿尤因肉瘤、骨肉瘤和横纹肌肉瘤的荧光引导手术:文献综述
Biomedicines. 2021 Oct 4;9(10):1388. doi: 10.3390/biomedicines9101388.
7
The cancer-related transcription factor Runx2 combined with osteopontin: a novel prognostic biomarker in resected osteosarcoma.癌症相关转录因子 Runx2 与骨桥蛋白结合:切除骨肉瘤中的新型预后生物标志物。
Int J Clin Oncol. 2021 Dec;26(12):2347-2354. doi: 10.1007/s10147-021-02025-4. Epub 2021 Sep 21.
8
Identification of tumorigenicity-associated genes in osteosarcoma cell lines based on bioinformatic analysis and experimental validation.基于生物信息学分析和实验验证鉴定骨肉瘤细胞系中与致瘤性相关的基因
J Cancer. 2020 Mar 26;11(12):3623-3633. doi: 10.7150/jca.37393. eCollection 2020.
9
Silencing of synaptotagmin 7 regulates osteosarcoma cell proliferation, apoptosis, and migration.沉默突触结合蛋白 7 调节骨肉瘤细胞增殖、凋亡和迁移。
Histol Histopathol. 2020 Mar;35(3):303-312. doi: 10.14670/HH-18-174. Epub 2019 Oct 21.
10
Modeling WWOX Loss of Function : What Have We Learned?WWOX功能丧失的建模:我们学到了什么?
Front Oncol. 2018 Oct 10;8:420. doi: 10.3389/fonc.2018.00420. eCollection 2018.
人类骨肉瘤中血管内皮生长因子(VEGF)通路基因(包括 VEGFA)的遗传扩增。
Cancer. 2011 Nov 1;117(21):4925-38. doi: 10.1002/cncr.26116. Epub 2011 Apr 14.
4
MDM2 and CDK4 immunohistochemistry is a valuable tool in the differential diagnosis of low-grade osteosarcomas and other primary fibro-osseous lesions of the bone.MDM2 和 CDK4 免疫组化在低级别骨肉瘤和其他骨原发性纤维骨性病变的鉴别诊断中具有重要价值。
Mod Pathol. 2011 May;24(5):624-37. doi: 10.1038/modpathol.2010.229. Epub 2011 Feb 18.
5
Frequent attenuation of the WWOX tumor suppressor in osteosarcoma is associated with increased tumorigenicity and aberrant RUNX2 expression.骨肉瘤中 WW0X 肿瘤抑制因子的频繁失活与致瘤性增加和 RUNX2 表达异常有关。
Cancer Res. 2010 Jul 1;70(13):5577-86. doi: 10.1158/0008-5472.CAN-09-4602. Epub 2010 Jun 8.
6
The etiology of osteosarcoma.骨肉瘤的病因
Cancer Treat Res. 2009;152:15-32. doi: 10.1007/978-1-4419-0284-9_2.
7
Deletion of the WWOX gene and frequent loss of its protein expression in human osteosarcoma.人类骨肉瘤中 WW0X 基因缺失及其蛋白表达频繁丢失。
Cancer Lett. 2010 May 1;291(1):31-8. doi: 10.1016/j.canlet.2009.09.018. Epub 2009 Nov 6.
8
Prognostic implication of immunohistochemical Runx2 expression in osteosarcoma.免疫组化检测Runx2表达在骨肉瘤中的预后意义
Tumori. 2009 May-Jun;95(3):311-6. doi: 10.1177/030089160909500307.
9
Identification of interactive networks of gene expression associated with osteosarcoma oncogenesis by integrated molecular profiling.通过综合分子谱分析鉴定与骨肉瘤发生相关的基因表达相互作用网络。
Hum Mol Genet. 2009 Jun 1;18(11):1962-75. doi: 10.1093/hmg/ddp117. Epub 2009 Mar 13.
10
Cell cycle regulator gene CDC5L, a potential target for 6p12-p21 amplicon in osteosarcoma.细胞周期调节基因CDC5L,骨肉瘤中6p12 - p21扩增子的潜在靶点。
Mol Cancer Res. 2008 Jun;6(6):937-46. doi: 10.1158/1541-7786.MCR-07-2115.